Byolete

Mounjaro Risks- Should You Be Worried

Listen Later

Welcome to The Chemist Couple podcast! With GLP-1 medications like Mounjaro becoming more popular, are we overlooking the risks? From potential nutrient deficiencies to serious health concerns like pancreatitis and diabetic retinopathy, we break it all down. Don't let the hype overshadow the science! ⚠️

 

⏱️ Timestamps:

 

  • 00:00 - The Rise of GLP-1s: Why Are They So Popular?
  • 01:56 - Eating Less = Harm? The Hidden Risks
  • 03:43 - Losing Lean Mass: What You Need to Know
  • 04:55 - The Risk of Vitamin Deficiencies
  • 05:58 - Can You Keep the Weight Off? Leptin Explained
  • 07:51 - Lifestyle Changes: Key to Long-Term Success
  • 10:18 - The ‘Golden Dose’: A Dangerous Shortcut?
  • 11:57 - ‘Microdosing’ GLP-1s: Risky & Unlicensed!
  • 14:31 - Surgery & Aspiration: A New GLP-1 Warning
  • 18:36 - Just How Powerful Are GLP-1s?
  • 19:32 - Diabetic Retinopathy: An Overlooked Side Effect
  • 22:05 - Pancreatitis: A Rare but Serious Risk
  • 23:55 - Fertility, Pregnancy & Breastfeeding: What’s Safe?
  • 29:20 - Planning a Pregnancy? Here’s What to Consider
  • 30:21 - Final Thoughts: Are GLP-1s Worth the Risk?

    •  

    🔔 Subscribe to The Chemist Couple Podcast:


    Stay on top of the latest science-based preventative health tips. Hit the like button and tell us: What are your thoughts on GLP-1 medication?

     

    🎙️ Listen to our podcast:


    Spotify 🎧: The Chemist Couple Podcast
    Apple Podcasts 🍏: The Chemist Couple Podcast

    📩 Sign up for our newsletter to learn how we personally apply science to enhance our lifestyle: Join Here

    📺 Watch this episode on YouTube: The Chemist Couple Podcast

     

    📚 Studies Referenced in This Episode:

     

    • Guyton & Hall Medical Physiology (14th Edition) – General physiology overview
    • Rang & Dale’s Pharmacology (10th Edition) – General pharmacological overview
    • Electronic Medicines Compendium (EMC): Mounjaro (tirzepatide) Summary of Product Characteristics – Read Here
    • Diabetes & Primary Care, Vol 23 No 4 (2021): GLP-1 receptor agonists and diabetic retinopathy – Read Here

      • ⚠️ Disclaimer: This podcast is for informational purposes only and should not replace advice from a healthcare professional. If you have any questions, reach out to us. Thanks for watching!

       

      ...more
      View all episodesView all episodes
      Download on the App Store
      ByoleteBy Byolete